United Kingdomapeiron-investments.com
Also known as Apeiron.
None yet. When a new project in the record names Apeiron Investment Group as owner, partner or investor, it shows here.
Adds BPL-003 (mebufotenin benzoate intranasal) and VLS-01 (DMT buccal); upfront $6.75/share plus up to $2.50/share CVR tied to development, regulatory and DEA-rescheduling milestones.
